Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
株式のランク #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
株価
$4.00
最終同期: 2026-08-20
時価総額
$75.37M
変化(1日)
0.00%
変化(1年)
12.99%
US
取引 RetinalGenix Technologies Inc. (RTGN)

カテゴリー

RetinalGenix Technologies Inc.(RTGN)の利益
2026 時点の利益 TTM: 0
RetinalGenix Technologies Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
RetinalGenix Technologies Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
- -
DE